IRIS
QUARTUCCIO, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.851
EU - Europa 2.856
AS - Asia 840
AF - Africa 39
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 6
OC - Oceania 2
Totale 14.600
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.795
UA - Ucraina 1.039
DE - Germania 448
CN - Cina 424
IT - Italia 416
FI - Finlandia 283
IE - Irlanda 235
SE - Svezia 195
TR - Turchia 139
GB - Regno Unito 114
SG - Singapore 92
VN - Vietnam 80
CA - Canada 55
IN - India 41
IR - Iran 24
FR - Francia 23
CZ - Repubblica Ceca 21
TG - Togo 20
BE - Belgio 18
JP - Giappone 14
EG - Egitto 12
HK - Hong Kong 12
PL - Polonia 11
NL - Olanda 10
RU - Federazione Russa 10
ES - Italia 6
EU - Europa 6
KR - Corea 6
RO - Romania 5
EE - Estonia 4
PT - Portogallo 4
CL - Cile 3
TW - Taiwan 3
ZA - Sudafrica 3
AL - Albania 2
AT - Austria 2
CH - Svizzera 2
GR - Grecia 2
IL - Israele 2
MA - Marocco 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AU - Australia 1
BO - Bolivia 1
BR - Brasile 1
ET - Etiopia 1
HR - Croazia 1
LI - Liechtenstein 1
LT - Lituania 1
LV - Lettonia 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
ZM - Zambia 1
Totale 14.600
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.633
Ann Arbor 1.122
Fairfield 1.060
Houston 952
Chandler 767
Jacksonville 678
Ashburn 527
Wilmington 519
Seattle 431
Dearborn 414
Cambridge 335
Dublin 232
Beijing 229
Princeton 229
Udine 171
Izmir 137
Dong Ket 80
San Diego 78
Boardman 67
Des Moines 60
Ogden 60
Singapore 54
Norwalk 50
Redmond 41
Ottawa 40
Nanjing 36
Hefei 29
San Mateo 26
Trieste 25
Munich 24
Brno 21
Lomé 20
New York 20
Brussels 17
Milan 17
Los Angeles 16
Auburn Hills 15
Falls Church 15
Kunming 15
Helsinki 13
Toronto 13
Augusta 12
Dallas 12
London 12
Grafing 11
Guangzhou 11
Leawood 11
Simi Valley 11
Chengdu 10
Saint Louis 10
Warsaw 10
Ardabil 9
Hyderabad 9
Nanchang 9
Phoenix 9
Amsterdam 8
Hong Kong 8
Jinan 8
Redwood City 8
Wuhan 8
Lappeenranta 7
Mumbai 7
Rome 7
Fuzhou 6
Monmouth Junction 6
Paris 6
Shenyang 6
Xian 6
Andover 5
Edinburgh 5
Hangzhou 5
Maserada Sul Piave 5
Washington 5
Baotou 4
Cagliari 4
Chicago 4
Codroipo 4
Indiana 4
New Orleans 4
Tallinn 4
Tappahannock 4
Verona 4
Vicenza 4
Albolote 3
Buffalo 3
Florence 3
Menlo Park 3
Pisa 3
Quzhou 3
Rovigo 3
Saint Petersburg 3
Shanghai 3
Tavagnacco 3
Tokyo 3
Treviso 3
Venezia 3
Zhengzhou 3
Al Qahirah al Jadidah 2
Albufeira 2
Alexandria 2
Totale 10.638
Salva come PNG Salva come JPEG
Nome #
Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study. 152
Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. 147
Validation of the classification criteria for cryoglobulinaemic vasculitis. 137
Pain management in cryoglobulinaemic syndrome 137
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study 135
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 134
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 129
Prevalence of mixed cryoglobulinaemia syndrome and circulating cryoglobulins in a population-based survey: the Origgio study. 126
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides. 123
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 123
Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome 122
Use of teriparatide in osteoporosis due to active rheumatic diseases 121
Increased genomic instability following treatment with direct acting anti-hepatitis C virus drugs 120
Apheresis treatment of cryoglobulinemic vasculitis: A multicentre cohort study of 159 patients 120
Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy. 118
Differentiation between early rheumatoid and early psoriatic arthritis by the ultrasonographic study of the synovio-entheseal complex of the small joints of the hands 118
Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis 118
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 116
Cost-effectiveness analysis of two Rituximab retreatment regimens for longstanding rheumatoid arthritis. 116
AB0695 Anti-prothrombin/phosphatidyl-serine complex autoantibodies in antiphospholipid syndrome: Preliminary data using a new ELISA method 114
Gitelman syndrome disclosed by calcium pyrophosphate deposition disease: Early diagnosis by ultrasonographic study 114
Pachydermodactyly: The role of ultrasonography and dermoscopy for diagnosis 114
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study. 114
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. 114
The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis 112
Patient-reported impact of spondyloarthritis on work disability and working life: The ATLANTIS survey 112
Optimizing the dose of mycophenolate mofetil for the maintenance treatment of lupus nephritis by therapeutic drug monitoring. 110
Development of the ClinESSDAI: A clinical score without biological domain. A tool for biological studies 110
HCV-related liver and lymphoproliferative diseases: Association with polymorphisms of IL28B and TLR2 109
Retrospective analysis of the usefulness of a protocol with high-dose methotrexate in polymyalgia rheumatica: Results of a single-center cohort of 100 patients 109
Accuracy of Computer-Guided Flapless Implant Surgery in Fully Edentulous Arches and in Edentulous Arches With Fresh Extraction Sockets 109
BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands 108
Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution 108
Role e of oral cyclophosphamide in the treatment of giant cell arteritis 107
Classification of cryoglobulinemic vasculitis 105
Introducing treat-to-target strategies of autoimmune extrahepatic manifestations of chronic hepatitis C virus infection 105
Acetaminophen-induced liver injury in a woman with febrile flare of systemic lupus erythematosus 105
Efficacy of intravenous cyclosporine in a case of cytophagic histiocytic panniculitis complicated by haemophagocytic syndrome after visceral leishmania infection 102
Treatment of rheumatoid arthritis with rituximab: an update and possible indications. 101
L. Quartuccio, M. Fabris, M. Maset, E. Pontarini, A. Zabotti, S. De Vita Bone marrow b-cell expansion in mixed cryoglobulinemia: association with nephritis and response to rituximab 100
Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy. 100
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis 100
Gastrointestinal Involvement in Systemic Vasculitis 100
Strontium ranelate and femural fracture healing during rheumatoid arthritis and osteoporosis 99
B lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis 98
Rituximab monotherapy, rather than rituximab plus antiviral drugs, for initial treatment of severe hepatitis C virus-associated mixed cryoglobulinemia syndrome: comment on the article by Terrier et al 97
Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia Vasculitis 97
Mycophenolic Acid AUC estimation in patients with lupus nephritis using an algorithm validated in an heart transplanted population 96
Dermoscopy of nail fold and elbow in the differential diagnosis of early psoriatic arthritis sine psoriasis and early rheumatoid arthritis 96
Late relapses of hepatitis C virus-cured mixed cryoglobulinaemia associated with infection or cancer 95
Variations in lumbar and femural bmd after rituximab therapy in active rheumatoid arthritis 94
A B-cell activating factor receptor (BAFF-R) His159Tyr mutation in Sjögren's Syndrome related lymphoproliferation 94
Development of type II mixed cryoglobulinaemic syndrome after effective and persistent hepatitis C virus eradication. 93
Type I interferon signature may influence the effect of belimumab on immunoglobulin levels, including rheumatoid factor in Sjögren's syndrome 93
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization. 93
A randomized, controlled, multicenter phase III study of the efficacy and safety of rituximab (rtx) monotherapy versus the best available treatment (bat) in patients with mixed cryoglobulinemia syndrome (MC) 92
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 92
Preliminary classification criteria for the cryoglobulinaemic vasculitis 91
A randomized controlled trial of rituximab for treatment of severe cryoglobulinemic vasculitis. 91
efficacy of methotrexate in polymyalgia rheumatica 90
A randomized, controlled, multicenter phase iii study of the efficacy and safety of rituximab (rtx) monotherapy versus the best available treatment (bat) in patients with mixed cryoglobulinemia syndrome (MC) Ann Rheum Dis 2010;69(Suppl3):93 90
Efficacy and tolerability of repeated cycles of a once-weekly regimen of bortezomib in lupus. 90
Delayed Positivization of Cerebral Angiography in Reversible Cerebral Vasoconstriction Syndrome (RCVS) Presenting with Recurrent Subarachnoid Haemorrhage. 90
Pleuritis is a red flag for Adult-onset Still's disease which may require biologic therapies. 89
Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study. 88
Long-term efficacy and improvement of health-related quality of life in patients with Takayasu's arteritis treated with infliximab. 87
Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study 86
Pregnancy and fetal outcome in patients with an established diagnosis of primary sjögren's syndrome 85
Safety of Rituximab in different rheumatic autoimmune diseases. A single centre experience in 85 cases. 2008 85
Efficacy of belimumab and targeting of rheumatoid factor-positive B-cell expansion in Sjögren's syndrome: follow-up after the end of the phase II open-label BELISS study 85
Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients 85
Myositis in primary sjögren's syndrome: data from a multicenter cohort 84
High prevalence of Chlamydophila psittaci subclinical infection in Italian patients with Sjögren's syndrome and parotid gland marginal zone B-cell lymphoma of MALT-type. 84
B-Lymphocyte Stimulator (BLyS) in mixed cryoglobulinemia sindrome: pathobiological and clinical implication 84
The-308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritis 83
Fetal Outcome in Patients with an Established Diagnosis of Primary Sjögren’s Syndrome 82
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 82
prevalence of chlamydophila psittaci subclinical infection in italian patients with rheumatoid arthritis: etiopathological and therapeutic implications 81
Primary sjögren's syndrome as a multi-organ disease: Impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients 81
Rheumatoid factor positivity, a lower disability and a lower number of anti-tnf agents failed are associated with response to rituximab in rheumatoid arthritis 81
Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients 79
Rituximab as possible first-line therapy for glomerulonephritis in HCV-related mixed cryoglobulinaemia 78
The role of the il-6 promoter p in predicting rituximab efficacy in rheumatoid artolymorphism 78
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer 78
A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren's syndrome. 77
A clinical-genetic score to identify surgically resected colorectal cancer patients benefiting from an adjuvant fluoropyrimidine-based therapy 77
Early Psoriatic Arthritis Versus Early Seronegative Rheumatoid Arthritis: Role of Dermoscopy Combined with Ultrasonography for Differential Diagnosis 77
Efficacy of Belimumab On Non-Malignant Parotid Swelling and Systemic Manifestations of Sjo¨gren’s Syndrome: Results of the Beliss Study. 76
Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes 76
Articular and peripheral nervous system involvement are linked to the long-term outcome in primary Sjögren's syndrome: The relevance of single organ manifestations rather than a composite score as predictors 76
Association be tween B cell clonal expansion and glomerulonephritis in type cryoglobulinnaemia. 2007; 66 (Suppl. II): 121 75
Gastrointestinal involvement in systemic vasculitis 75
Disappearance of bone marrow B cell clonal expansion in patients with type II hepatitis C virus-related cryoglobulinemic glomerulonephritis after clinical efficient rituximab therapy. 74
Is salivary gland ultrasonography a useful tool in Sjögren's syndrome? A systematic review 74
Clinical characterization and treatment outcome in a monocentric cohort of 45 patients with adult onset still's disease. 73
Rituximab in mixed cryoglobulinemia: increased experience and perspectives 73
Cryoglobulinemia in Sjögren Syndrome: A Disease Subset that Links Higher Systemic Disease Activity, Autoimmunity, and Local B Cell Proliferation in Mucosa-associated Lymphoid Tissue 73
Long-term response to rituximab in 36 patents with the reumatoid arthritis: a single centre wxperience. 72
Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia. 72
Efficacy of cyclosporin-A in the long-term management of thrombocytopenia associated with systemic lupus erythematosus 72
Totale 9.802
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.555
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.555
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.265 0 150 104 470 235 585 401 412 254 319 91 244
2020/20212.489 78 270 52 274 103 275 67 258 527 84 325 176
2021/20221.678 62 173 89 138 44 48 91 109 25 235 369 295
2022/20232.035 248 95 38 221 208 544 35 147 296 38 77 88
2023/2024763 109 62 29 19 144 89 30 64 99 60 21 37
2024/2025204 121 83 0 0 0 0 0 0 0 0 0 0
Totale 15.394